J Korean Pain Soc.  2002 Dec;15(2):121-125.

Effects of Prolotherapy on Chronic Musculoskeletal Disease

Affiliations
  • 1Department of Anesthesiology, College of Medicine, Kyungpook National University, Taegu, Korea. kimsh73@yahoo.co.kr

Abstract

BACKGROUND: Musculoskeletal injury is a major cause of chronic pain due to a weakness of the tendons and ligaments. Currently, prolotherapy is used for treating chronic pain by strengthening the tendons and ligaments. This study was designed to evaluate the effects of prolotherapy on chronic musculoskeletal diseases.
METHODS
Twenty chronic musculoskeletal disease patients were injected with a 12.5% dextrose solution as a proliferent and the side effects were checked. The VAS (visual analogue scales) were measured before the injection and 2 months after the injection.
RESULTS
This study showed that a post-prolotherapy VAS was significantly reduced compared to the pre-prolotherapy VAS in 80% of subjects, and the average ratio of the post-prolotherapy VAS to the pre-prolotherapy VAS was 0.36. There were several side effects such as pain after the injection, dizziness during injection, new pain development, and a hematoma.
CONCLUSIONS
Prolotherapy is another good method for treating chronic musculosketal diseases that respond poorly to conventional treatments like a trigger point injection, a nerve block, medication, etc.

Keyword

Musculoskeletal disease; Prolotherapy

MeSH Terms

Chronic Pain
Dizziness
Glucose
Hematoma
Humans
Ligaments
Musculoskeletal Diseases*
Nerve Block
Tendons
Trigger Points
Glucose
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr